Read on...
Scroll down to read deal descriptions. Your suggestions and comments support the democratisation of M&A data. If you'd like to contribute to the future editions, drop us a line.
AMERICAS
Viatris, a global healthcare company, completed the acquisition of Pacira BioSciences, a provider of innovative non-opioid pain therapies, for c. $1.69bn.
Sixth Street, a global investment firm, completed the acquisition of a minority stake in Chomps, a meat snack brand, from Stride Consumer Partners, a private equity firm, for $350m, according to press releases.
Chomps was advised by Piper Sandler, Giannuzzi Lewendon and Zeno Group. Sixth Street was advised by Goldman Sachs and Latham & Watkins (led by John Miller, Haim Zaltzman and Matthew M. Delja). Stride Consumer Partners was advised by William Blair & Co, according to press releases and MergerLinks data.
Bertram Capital, a private equity firm, completed the acquisition of Medical Technology Associates, a US provider of regulatory-driven testing, inspection, certification and calibration services, from Riverarch Equity Partners, a private equity firm, according to press releases. Financial terms were not disclosed.
EQT, a global investment organization and private markets firm, agreed to acquire Flatiron Energy, a US-based developer and operator of utility-scale battery energy storage projects, from Hull Street Energy, a US private equity firm, according to press releases. Financial terms were not disclosed.
EQT is advised by Santander and Simpson Thacher & Bartlett. Flatiron Energy is advised by Guggenheim Partners and Kirkland & Ellis. Hull Street Energy is advised by Faegre Drinker Biddle & Reath, according to press releases.
The Carlyle Group and KKR, private equity companies, completed a $475m investment in Litmus Music, a company focused on acquiring and managing music rights, including both music publishing and recorded music, across multiple genres, geographies and vintages, according to press releases.
The Carlyle Group was advised by Evercore and Latham & Watkins. KKR was advised by Kirkland & Ellis. Litmus Music was advised by Evercore and Grandstand Media (led by Kate Jackson), according to press releases and MergerLinks data.
Enlightenment Capital, a private equity firm, completed the acquisition of a majority stake in Cadmus, a US-based provider of technology-enabled advisory and implementation services for government and commercial organisations, according to press releases. Financial terms were not disclosed.
Enlightenment Capital was advised by Berenson & Co and Moore & Van Allen. Cadmus was advised by Houlihan Lokey and Morrison Foerster (led by Tyler Sewell), according to press releases and MergerLinks data.
Shore Capital Partners-backed Everis Medical, a medical device company specializing in otolaryngology, completed the merger with Hemostasis, an innovator in advanced sinus dressings and surgical hemostats, according to press releases. Financial terms were not disclosed.
Shore Capital Partners and Everis Medical were advised by DLA Piper. Shore Capital Partners was advised by Cain Brothers. Hemostasis was advised by Piper Sandler and Fox Rothschild, according to press releases.
Centerbridge Partners, a multi-strategy private investment firm, completed the acquisition of Amplix, a technology advisory firm, from Gemspring Capital, a private equity firm, according to press releases. Financial terms were not disclosed.
Amplix was advised by Lazard and Kirkland & Ellis. Centerbridge Partners was advised by Guggenheim Partners and Simpson Thacher & Bartlett, according to press releases.
Decks & Docks, a family-owned specialty distributor of marine construction and outdoor living supplies, completed the acquisition of The Decking Superstore, a distributor of decking, siding, railing and outdoor building materials, according to press releases. Financial terms were not disclosed.
Decks & Docks was advised by Grant Thornton, Trenam Law and ICR (led by Chuck Dohrenwend and Caroline Roseman). The Decking Superstore was advised by Jeffer Mangels Butler & Mitchell, according to press releases.
AMPERA, a developer of advanced energy technologies focused on next-generation power generation and commercialization, agreed to go public via SPAC merger with Berto Acquisition, a provider of SPAC services, at a $900m valuation, according to press releases.
AMPERA is advised by Needham & Co and Sichenzia Ross Ference Carmel. Berto Acquisition is advised by White & Case, according to press releases.
UL Solutions, a US-based provider of testing, inspection, certification and safety-related software services, agreed to acquire Worldly, a US-based supply chain intelligence and sustainability software company, at an enterprise value of c. $350m, according to press releases.
Worldly is advised by Evercore and Ashurst Perkins Coie, according to press releases.
Greenoaks and Sequoia Capital, the investment companies, led a $5bn Series C round in Isomorphic Labs, an AI-first drug discovery and development company, with participation from Andreessen Horowitz, Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund, according to press releases.
General Atlantic, a global growth equity firm, and QED Investors, a venture capital firm, led a $250m Series B round in Model ML, an AI company that develops research automation platforms, with participation from Evolution Equity Partners, Airtree, Forestay Capital, Y Combinator, FT Partners, Latitude, Inception Fund and 13Books Capital, according to press releases.
Corporate-card startup Ramp raising funds at a $70bn valuation. ( WSJ)
Ramp is in early discussions to raise at least $1bn in a new funding round at a valuation exceeding $70bn, as the corporate-card and expense-management startup continues its rapid fundraising.
The potential financing would mark Ramp’s third funding round within a year, during which its valuation has more than doubled, supported by its expanding AI-powered financial management offerings.
Blue Sea Capital closes oversubscribed Fund IV at $800m. ( Press Release)
Blue Sea Capital has closed its fourth fund at $800m, exceeding its $550m target and raising approximately 29% more than its predecessor fund.
Fund IV will invest exclusively in healthcare businesses valued at up to $500m, focusing on healthcare products, technology-enabled services, outsourced services, and multi-site healthcare platforms.
EMEA
Eurobank, a Greek banking group, agreed to acquire a 65% stake in Fibank, a Bulgarian commercial bank, for €650m. Following completion, Eurobank intends to launch a mandatory tender offer for the remaining shares, according to press releases.
Eurobank is advised by Grant Thornton, JP Morgan, UBS, Boyanov & Co, Milbank and PotamitisVekris, according to press releases.
NEO NEXT+, an Aberdeen-headquartered oil and gas producer, agreed to acquire the UK North Sea upstream business of EnQuest, an independent energy company, for up to $960m, according to press releases.
Premji Invest, Khosla Ventures and Eclipse, the investment firms, led a $500m Series A funding round in Genesis AI, a robotics company developing AI-powered general-purpose robots, with participation from Durable Capital Partners, T. Rowe Price, Bpifrance, HSG, NVIDIA, AMD Ventures, Zoom, Samsung Next, Ericsson and individual investors, including Eric Schmidt, Eric Yuan, Jerry Yang, Xavier Niel and Zach Kirkhorn, according to press releases.
Goldman Sachs Alternatives, an alternative investments firm, led a $280m Series C round in Payhawk, a developer of a business spend management platform, with participation from QED, Greenoaks, Lightspeed, Hedosophia, Bek Ventures, Galdana Ventures, Cogito Capital, Inveready, Invus, Tomas Okmanas and Didac Lee, according to press releases.
British cancer drug developer Ellipses Pharma considers London listing. ( Reuters)
British cancer drug developer Ellipses Pharma is exploring a London listing through a reverse takeover by SPAC Wolfram Resources, targeting a valuation of £450m–£500m ($594m–$660m).
The company aims to complete the transaction by early 2027, alongside an equity fundraising to support development of its cancer treatments. Deal terms remain under negotiation.
APAC
Canada's La Caisse in talks for stake in Bain's Bridge Data Centres. ( Reuters)
Canadian pension fund La Caisse is in advanced talks to acquire a stake in Bain Capital-backed Bridge Data Centres, with a potential transaction valuing the Singapore-based operator at $4bn–$5bn.
Bain Capital is considering selling a substantial portion of its holdings, potentially up to half, with a deal possible in the coming weeks. Discussions remain non-exclusive, and final terms have not been agreed.
EQT is said to consider selling India's biggest IVF chain Indira. ( Reuters)
EQT is exploring a potential sale of Indian fertility services provider Indira IVF Hospital, seeking a valuation of at least $1.5bn.
The Swedish private equity firm is working with an adviser on the possible divestment, although discussions remain preliminary and no transaction has been agreed.
Boyuan Capital completes final close of CNY1.1bn Fund II, focusing on industrial AI and globalization. ( Press Release)
Boyuan Capital, Bosch Group’s investment platform in China, has closed its second fund at approximately CNY1.1bn ($125m), backed by institutional and industrial investors including German equipment manufacturer STIHL.
The fund will focus on industrial AI, robotics, intelligent manufacturing, and the international expansion of Chinese technology companies. It has already invested in seven businesses, including Bowintec, Linkhou Robotics and Inspire Robots.
|